DHODH and acute myeloid leukemia: In addition, cytarabine induced differentiation ex vivo in a subset of primary AML samples that are sensitive to AICAr and DHODH inhibitor (12, 15), suggesting that differentiation in response to LDAC may share mechanisms with those used by de novo pyrimidine synthesis inhibitors.